Chelation Therapy Endorsed by a Bypass Surgeon With a Case report 一位心臟外科醫師為螯合治療背書（附案例報告）

EDTA: A Life-Changing Experience 　　 EDTA：一個改變生命的經驗

As a conventionally trained cardiovascular surgeon, the concept of free-radical pathology causing atherosclerotic vascular disease was not included in the curriculum. EDTA chelation was not a treatment option for our patients. Vitamins and minerals were not considered a valuable adjuvant to the advanced technology of angioplasty and bypass surgery. My dream of being a heart surgeon was becoming reality. However, I discovered a real problem. We were delivering symptomatic therapy and ignoring the disease process. The patients were encouraged to stop smoking, change their diet, exercise, and alter their lifestyle. Most patients were unsuccessful and were sent home for the untreated disease to continue its progression against health and life. 

身為一個正統醫學訓練出身的心臟外科醫師，自由基導致動脈硬化性血管疾病的理論原不在我們的訓練內容當中，當然EDTA螯合治療並非我們治療的選項之一，而維他命和礦物質等營養品對於尖端的血管手術及冠狀動脈繞道手術也並非有價值的輔助治療。當我想要成為一個心臟外科醫師的夢想將要實現的時候，我發現了一個現實的問題：我們總是對病患做症狀治療，卻忽視疾病本身仍在持續惡化的事實。病患被建議要停止吸菸、改變飲食習慣、運動、調整生活習慣，但是，大多數的患者並沒有辦法做到，於是，患者回到現實生活後，他的疾病依然持續惡化並持續影響他的健康和生命。

I was first encouraged to learn about the possible benefit of vitamin E for cardiac patients. Research led me to believe there was in fact enough evidence to substantiate the inclusion of vitamin E in my treatment protocol. There was still more I needed to learn, and I continued my quest for knowledge. I then discovered the concept of free-radical damage to the vascular endothelial cell membrane leading to plaque formation and stenosis. The addition of EDTA and a more intense vitamin regimen has provided many of my patients with the opportunity to experience improvement and healing even without surgery. The case history of one of these patients serves as an example of this truth. 

最初，我開始探索維他命Ｅ對心臟病患者的益處，文獻報告使我相信我可以將維他命Ｅ納入我的治療計畫當中，但我知道我需要了解更多，於是我繼續研究，接著我發現自由基會造成血管內皮細胞膜的傷害，導致動脈硬化斑塊的產生與血管狹窄，而若使用EDTA治療和更積極的維他命補充，也可以在不需手術的情況下讓病患有機會復原。下面這個例子便是患者們的實證之一：

A 72-year-old man presented to the Surgery Clinic and Vascular Treatment Center for continuation of chelation therapy because of atherosclerotic coronary artery disease. The first coronary artery bypass surgery performed after a myocardial infarction was unsuccessful. A second coronary artery bypass also resulted in angina that severely limited his level of activity and threatened to decrease his life expectancy. Post-surgical medical management failed to improve his condition. He was sent home with no hope for improvement and no other options.

一個72歲的男性來到我的外科診所及血管疾病治療中心，希望針對他的動脈硬化性冠狀動脈疾病繼續做重金屬螯合治療。他在發生了心肌梗塞之後做過兩次冠狀動脈繞道手術，但仍舊有心絞痛的症狀，這不但嚴重限制他的日常活動，甚至威脅到他的生命，術後的藥物治療並沒有改善他的症狀，而即使症狀的改善毫無希望，醫師也沒有給他其它選擇。

Determined to find help for his failing heart, he discovered chelation therapy. With chelation, there was immediate improvement with reduction of anginal episodes and an increase in work capacity. EDTA chelation was given twice weekly and then reduced to monthly therapy after 30 treatments. Over 200 chelation treatments have been given since the initial medical and surgical therapy failure 22 years ago. For longer than 2 decades he has enjoyed complete symptomatic relief with no activity restriction. He was faced with the reality of an early death after his bypass surgeries failed, and was instructed to go home and enjoy the little time left to him. Chelation has truly been a gift of extended life for this gentleman.

於是他遍尋可以改善他心臟疾病的治療方式，而發現了重金屬螯合治療。治療之後，心絞痛的頻率立刻降低了，他工作的耐受力也提高了，於是他接受了每月兩次的EDTA螯合治療，十五個月後仍接受每月一次的治療。至今，距離藥物和手術治療失敗已經廿二年過去了，他總計接受了超過兩百次的治療，而這段時間當中，他完全沒有心臟的症狀，活動力也沒有受到疾病的限制。回想當初，廿幾年前，他面對的是繞道手術失敗後可能英年早逝的事實，他被醫師建議回家好好享受所剩無幾的日子。螯合治療對他來說真可說是上天掉下來的禮物。

Recently, this same patient was scheduled for coronary angiography in preparation for gallbladder surgery. His surgeon requested this study because of his cardiac history. The arteriogram showed no significant coronary artery disease. Twenty-two years earlier, there was documented coronary artery blockage sufficient to warrant 2 bypass surgeries. He tolerated the gallbladder surgery without incident. EDTA chelation therapy is being continued on a monthly basis. He remains active without symptoms or restriction of activity.

最近，這個患者準備要接受膽囊手術，但醫師基於他冠狀動脈心臟病的病史而為他安排了心臟血管攝影，這個檢查在廿二年前曾經發現他有嚴重的冠狀動脈阻塞而使他必須接受兩次繞道手術，然而這次的檢查卻顯示他沒有明顯的冠狀動脈疾病，於是他接受了膽囊手術，也沒有任何併發症發生。現在，他仍持續每月接受一次EDTA螯合治療，他的生活仍持續充滿活力，沒有心臟症狀，更沒有活動的限制。

In conclusion, this history represents a patient with coronary artery atherosclerotic disease twice leading to myocardial infarction and bypass surgery. When the second surgery also ended in failure, he was given no hope for recovery. After more than 200 chelation treatments, an arteriogram demonstrated total reversal of the atherosclerotic process suggesting healing of a disease that is the number one cause of death and disability in America today.

總結來說，這個患者的病史告訴我們：一個因為冠狀動脈硬化導致兩次心肌梗塞並接受兩次繞道手術的患者，在被告知沒有希望時，卻在超過兩百次的螯合治療之後，由追蹤的心血管攝影來證實：他的動脈硬化疾病已經痊癒，而這個疾病卻是美國今日造成死亡與殘障的第一大病因。

The inclusion of EDTA chelation as a treatment for atherosclerotic vascular disease has been the single best therapeutic addition to my practice of general and vascular surgery, which began 19 years ago. 

從十九年前開始，在我治療一般及血管外科疾病的執業過程中， EDTA螯合治療就已經是我治療動脈硬化性血管疾病唯一且最好的選擇。
H. J. H.
MD Vascular, Thoracic and General Surgery
Reference
Letter to the Editor. Clinical Practice of Alternative Medicine 2000; Volume 1, Number 3.